Skip to main content
someone in lab using a multi pippitte

4 months ago

UNC-Chapel Hill receives $65M from NIH for antiviral drug development center

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health awarded the UNC Gillings School of Global Public Health a $65 million grant establishing an Antiviral Drug Discovery Center to develop oral antivirals that can combat pandemic-level viruses like COVID-19. The center builds upon and is tightly affiliated with UNC’s Rapidly Emerging Antiviral Drug Development Initiative. The READDI-AViDD Center, one of nine established by the NIH, is an integrated public-private partnership with a renowned, interdisciplinary research team of experts from the Gillings School, UNC School of Medicine and UNC Eshelman School of Pharmacy. They will apply cutting-edge technologies to develop oral therapies that target viral families with high potential to cause a pandemic in the future.

Silvia Ramos

5 months ago

Ramos lab publishes RNA research in Nucleic Acids Research

Congratulations to Ramos lab and UNC collaborators for their recent publication in Nucleic Acids Research describing the discovery of a novel mRNA target, Elavl2, for the RNA binding protein, ZFP36L2. Congratulations to first-co-authors Ian C. Redmon and Matthew Ardizzone, undergraduate researchers in the Biochemistry and Biophysics department, and Hilal Hekimoğlu, an International visiting master’s student and to all authors!